title: Can we use EBV-DNA monitoring to predict disease relapse in EBV-positive hodgkin lymphoma patients?
authors.affiliation: Department of Clinical Hematology, University Hospital Kralovske Vinohrady and 3rd Faculty of Medicine, Charles University, Prague, Czech Republic. m.spacek@fnkv.cz
authors.forename: Martin
authors.initials: M
authors.lastname: Spacek
authors.forename: P
authors.initials: P
authors.lastname: Hubacek
authors.forename: J
authors.initials: J
authors.lastname: Markova
authors.forename: M
authors.initials: M
authors.lastname: Zajac
authors.forename: Z
authors.initials: Z
authors.lastname: Vernerova
authors.forename: T
authors.initials: T
authors.lastname: Kozak
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D004279:DNA, Viral / Q000097:blood*; D005260:Female; D004854:Herpesvirus 4, Human / Q000235:genetics*; D006689:Hodgkin Disease / Q000175:diagnosis* / Q000473:pathology / Q000821:virology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D011379:Prognosis; D012008:Recurrence; D019562:Viral Load; D055815:Young Adult
chemical_list: D004279:DNA, Viral